I am not aware of any studies addressing this specific question, the utility of hyaluronic acid derivatives in patients with RA and severe secondary OA. Because joint damage from previous RA can ...
STAINES-UPON-THAMES, United Kingdom, June 13, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global specialty biopharmaceutical company, is reporting that all primary and secondary outcome ...
Overall multibiomarker disease activity scores are insufficient for determining rheumatoid arthritis disease activity following repository corticotropin injection, according to data published in ...
STAINES-UPON-THAMES, United Kingdom, Nov. 12, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced data on patient-reported outcomes (PROs) showing ...
Rheumatoid arthritis infusions deliver biologic medications directly into the bloodstream to slow the disease’s progression, particularly when oral medications aren’t sufficient. Different types of ...
The New Drug Application for an additional rheumatoid arthritis (RA) indication of Methotrexate Injection has been accepted by NMPA, which is a new milestone following the China approval for psoriasis ...
TOKYO, Sept 26, 2022 - (JCN Newswire) - - Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac Gesellschaft fur klinische Spezialpraparate mbH announced today that they have obtained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback